XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Jun. 30, 2024
Current assets    
Cash and cash equivalents $ 6,518 $ 10,442
Short-term investments 21,790 21,474
Accounts receivable 91 77
Inventory, net:    
Raw materials 2,212 2,038
Work-in-process 177 66
Finished goods 309 370
Prepaid expenses and other current assets 515 261
Total current assets 31,612 34,728
Property, Plant and Equipment, Net 2,724 2,763
Operating lease assets 83 119
Other assets, net 30 30
Total assets 34,449 37,640
Liabilities, Current [Abstract]    
Accounts payable 649 373
Payroll related accruals 612 1,174
Accrued expenses and other liabilities 717 754
Operating and Finance Leases, Liability, Current 149 227
Total current liabilities 2,127 2,528
Accrued expenses and other liabilities, net of current portion 194 232
Operating and Finance Leases, Liability, Noncurrent 67 73
Total liabilities 2,388 2,833
Commitments and contingencies (Note 13)
Stockholders’ equity    
Convertible preferred stock, $0.001 par value, 2,500,000 shares authorized; 280,898 shares of Series D issued and outstanding at September 30, 2024 and June 30, 2024 0 0
Common stock, $0.001 par value, 250,000,000 shares authorized at September 30, 2024 and June 30, 2024, respectively; 1,712,045 shares issued at September 30, 2024 and June 30, 2024, respectively; 1,701,729 outstanding at September 30, 2024 and June 30, 2024, respectively 190,643 190,643
Treasury shares, 10,316 at September 30, 2024 and June 30, 2024, respectively (119) (119)
Additional paid-in capital 82,696 82,480
Accumulated deficit (240,298) (237,020)
Accumulated other comprehensive loss (861) (1,177)
Total stockholders’ equity 32,061 34,807
Total liabilities and stockholders’ equity $ 34,449 $ 37,640